Abstract
A young woman, bedbound with severe pulmonary hypertension, responded to intravenous epoprostenol with a fall in pulmonary vascular resistance, improved oxygenation, and a rise in exercise tolerance. For thirteen months, continuous infusion of epoprostenol has enabled her to live independently at home.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Blood Pressure / drug effects
-
Cardiac Output / drug effects
-
Epoprostenol / administration & dosage*
-
Female
-
Humans
-
Hypertension, Pulmonary / drug therapy*
-
Infusions, Parenteral
-
Pulmonary Circulation / drug effects
-
Time Factors
-
Vascular Resistance / drug effects